-
Shun Utsunomiya
Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan. Graduate School of Engineering, The University of Tokyo, Tokyo, Japan. Neuroscience 2, Laboratory for Drug Discovery and Disease Research, Shionogi & Co. Ltd., Toyonaka, Osaka, Japan. Business-Academia Collaborative Laboratory (Shionogi), Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
-
Yusuke Kishi
Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
-
Masafumi Tsuboi
Graduate School of Engineering, The University of Tokyo, Tokyo, Japan.
-
Daichi Kawaguchi
Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
-
Yukiko Gotoh
Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan. International Research Center for Neurointelligence (WPI-IRCN), The University of Tokyo, Tokyo, Japan.
-
Manabu Abe
Department of Animal Model Development, Brain Research Institute, Niigata University, Niigata, Japan.
-
Kenji Sakimura
Department of Animal Model Development, Brain Research Institute, Niigata University, Niigata, Japan.
-
Kazuma Maeda
Neuroscience 2, Laboratory for Drug Discovery and Disease Research, Shionogi & Co. Ltd., Toyonaka, Osaka, Japan. Business-Academia Collaborative Laboratory (Shionogi), Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
-
Hiroshi Takemoto
Neuroscience 2, Laboratory for Drug Discovery and Disease Research, Shionogi & Co. Ltd., Toyonaka, Osaka, Japan. Business-Academia Collaborative Laboratory (Shionogi), Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
